SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038591
Filing Date
2020-08-10
Accepted
2020-08-10 07:12:55
Documents
85
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20200630.htm   iXBRL 10-Q 2489285
2 EX-4.9 exhibit4_9.htm EX-4.9 91070
3 EX-10.1 exhibit10_1.htm EX-10.1 418677
4 EX-31.1 prtk-ex311_9.htm EX-31.1 18151
5 EX-31.2 prtk-ex312_7.htm EX-31.2 18315
6 EX-32.1 prtk-ex321_6.htm EX-32.1 6530
7 EX-32.2 prtk-ex322_8.htm EX-32.2 6423
  Complete submission text file 0001564590-20-038591.txt   10482495

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA prtk-20200630.xsd EX-101.SCH 84903
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20200630_cal.xml EX-101.CAL 52929
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20200630_def.xml EX-101.DEF 268210
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20200630_lab.xml EX-101.LAB 595311
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20200630_pre.xml EX-101.PRE 432835
13 EXTRACTED XBRL INSTANCE DOCUMENT prtk-10q_20200630_htm.xml XML 1764389
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 201087056
SIC: 2834 Pharmaceutical Preparations